ZYME 8-K 2026-09-23
Zymeworks Inc. (ZYME) 8-K dated 2026-09-23 — accession 0001193125-26-399383.
Zymeworks Inc. (ZYME) is a biotechnology company listed on NASDAQ.
Zymeworks Inc. filed a 8-K on 2026-09-23. Accession 0001193125-26-399383.
This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), New debt obligation (Item 2.03), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.
Not investment advice. The ZYME SEC hub lists recent forms. The stock page is the research view.